NASDAQ •
Healthcare •
Drug Manufacturers - General •
Quote as of 05/15/2026 14:28
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNASDAQ
Market Capitalization182,282 mln
Float538 mln
Earnings Date08/04/2026
EPS
14.37
Robust
P / E
22.80
Premium valuation
Piotroski F-Score
8
/ 9
Very strong
Beneish M-Score
-2.58
Likely reliable
1-Year Forecast
353
Modest upside
Relative Strength
55
/ 100
Slightly ahead
Business Description
Founded in 1980 and based in Thousand Oaks, California, Amgen is a global medicine company focused on developing and producing treatments for serious conditions such as cancer, bone disease, heart disease, and autoimmune disorders. The company sells a broad range of products to hospitals, clinics, and pharmacies, reaching patients through wholesale distributors. Amgen also works alongside several partner companies, including AstraZeneca and BeiGene, to expand its research and bring new treatments to market.
